These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 16104623)
41. Images in clinical medicine. Serpentine supravenous hyperpigmentation. Chan CC; Lin SJ N Engl J Med; 2010 Jul; 363(5):e8. PubMed ID: 20830826 [No Abstract] [Full Text] [Related]
42. 5-Flourouracil cardiotoxicity - an elusive cardiopathy: case report. Bhat GM; Mir MH; Showkat HI; Kasanna B; Bagdadi F; Sarmast AH; Qadri S Gulf J Oncolog; 2012 Jul; (12):70-2. PubMed ID: 22773220 [TBL] [Abstract][Full Text] [Related]
43. Rechallenging 5-Fluorouracil in a Patient With Capecitabine-Induced Ventricular Fibrillation. Lai S; Marshall JL; Morrissey RL Clin Colorectal Cancer; 2015 Sep; 14(3):198-201. PubMed ID: 25858685 [No Abstract] [Full Text] [Related]
44. Prolonged cardiogenic shock caused by a high-dose intravenous administration of dopamine in a patient with takotsubo cardiomyopathy. Abe Y; Tamura A; Kadota J Int J Cardiol; 2010 May; 141(1):e1-3. PubMed ID: 19135739 [TBL] [Abstract][Full Text] [Related]
45. A case of therapy-related acute myeloid leukemia following 5-fluorouracil chemotherapy. Park HJ; Choi JH; Lee KA; Kim HC; Nam YS; Oh YH; Lee WS Korean J Intern Med; 2012 Mar; 27(1):115-7. PubMed ID: 22403512 [No Abstract] [Full Text] [Related]
47. Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report. Kuropkat C; Griem K; Clark J; Rodriguez ER; Hutchinson J; Taylor SG Am J Clin Oncol; 1999 Oct; 22(5):466-70. PubMed ID: 10521060 [TBL] [Abstract][Full Text] [Related]
48. Cardiotoxicity of the antiproliferative compound fluorouracil. Becker K; Erckenbrecht JF; Häussinger D; Frieling T Drugs; 1999 Apr; 57(4):475-84. PubMed ID: 10235688 [TBL] [Abstract][Full Text] [Related]
49. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. Potter BJ N Engl J Med; 2021 Nov; 385(22):2107-2108. PubMed ID: 34818493 [No Abstract] [Full Text] [Related]
50. [Coma following chemotherapy: is 5FU implicated? Discussion about on case-report]. Heluwaert F; Santre C; Martin C; Hilleret MN; Martin D Gastroenterol Clin Biol; 2006 Feb; 30(2):325-6. PubMed ID: 16565673 [TBL] [Abstract][Full Text] [Related]
51. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. Gibson LE; Chang MG; Berra L N Engl J Med; 2021 Nov; 385(22):2108. PubMed ID: 34818494 [No Abstract] [Full Text] [Related]
52. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. Reply. Mathew R; Di Santo P; Hibbert B N Engl J Med; 2021 Nov; 385(22):2108-2109. PubMed ID: 34818495 [No Abstract] [Full Text] [Related]
53. The use of low-dose insulin in cardiogenic shock due to combined overdose of verapamil, enalapril and metoprolol. Hasin T; Leibowitz D; Antopolsky M; Chajek-Shaul T Cardiology; 2006; 106(4):233-6. PubMed ID: 16685130 [TBL] [Abstract][Full Text] [Related]
54. Vive la difference: sex and fluorouracil toxicity. Macdonald JS J Clin Oncol; 2002 Mar; 20(6):1439-41. PubMed ID: 11896088 [No Abstract] [Full Text] [Related]
55. Late infection of a 5-fluorouracil enhanced bleb following systemic chemotherapy. Kasetti SR; Hugkulstone CE Eye (Lond); 2000 Aug; 14 ( Pt 4)():668-9. PubMed ID: 11040924 [No Abstract] [Full Text] [Related]
56. Toxic cardiogenic shock associated with infusion of 5-fluorouracil. McKendall GR; Shurman A; Anamur M; Most AS Am Heart J; 1989 Jul; 118(1):184-6. PubMed ID: 2741789 [No Abstract] [Full Text] [Related]